Stone House Investment Management »

AstraZeneca shares owned by Stone House Investment Management

Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Stone House Investment Management from 13F filings

Historical chart of Stone House Investment Management investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Stone House Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Stone House Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.5k 45 77.91
2024-03-31 $3.0k 45 67.76

More positions owned by Stone House Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core Total Usd (IUSB)
Ishares Tr S&p 500 Grwt Etf (IVW)
Procter & Gamble Company (PG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Eafe Grwth Etf (EFG)
Ishares Tr Core Msci Total (IXUS)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr Mbs Etf (MBB)
Ishares Msci Emrg Chn (EMXC)
Ishares Tr U S Tech Etf (IYW)
Ishares Tr Core Us Aggbd Et (AGG)

View all positions for Stone House Investment Management

Top funds holding AstraZeneca

T. Rowe Price Associates
PRIMECAP Management Company
Capital Research and Management Company - Division 3
Wellington Management Company
Bank of America Corporation
FMR
Franklin Resources
Morgan Stanley
Jennison Associates
Sanders Capital
Fisher Investments
Goldman Sachs Group
Atlantic Trust
Citadel Advisors
Neuberger Berman Group

View all funds holding AstraZeneca